Braintale
French tech company | Builders Republic
About
Medtech platform that turns brain MRI scans into quantitative white-matter biomarkers — helping clinicians and pharma teams predict, diagnose and monitor neurological conditions, from coma, stroke and traumatic brain injury to Alzheimer's, Parkinson's and multiple sclerosis. CE-marked SaaS medical device (brainTale-care).
Key facts
- Status
- Morte
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2018
- City
- STRASBOURG
- Region
- Grand Est
- Tracked rounds
- 1
- Amount raised
- 4.5 M€ raised since 2020
Funding rounds
- Series A — 2023
Investors
Notes
Redressement judiciaire ouvert le 17/03/2025, converti en liquidation judiciaire avec cessation immédiate d'activité (cessation des paiements fixée au 01/12/2024). Liquidateur SELARL MJ Synergie (Me Nicolas Flesch).